The contract extension from Medibank till June 2019 is a welcome and reassuring news.
For me, this announcement is price sensitive as Medibank is a heavyweight contributor to KKT revenue.
As an investor, besides wishing that all synergies and transition post the merger will be smooth.
I can not deny that I am starting to be excited about the expansion, diversity and the growth prospect of this Low profile company.
Although not reinventing the wheel, the services on offer are required in the well-being of our economy
and society.
We know the company is undervalued currently, it will take time to clear some access shares in the market
and the flow of more good news will take care of that.
Satisfied that I have purchased extra shares on the market when the price dropped below 50 'c during the CR.